Blistex acquires Stri-Dex acne line, Dairy Ease brand from Bayer.
This article was originally published in The Tan Sheet
Executive Summary
BLISTEX ADDING $20 MIL. STRI-DEX ACNE BRAND to its OTC business, the company announced March 11. The purchase of the Stri-Dex acne treatment line from Bayer's Consumer Care division gives Oakbrook, Ill.-based Blistex an 8.1% dollar share, or a fourth-place slot, in the $254 mil. combined acne remedy market in U.S. food, drug and mass merchandise outlets, according to Information Resources Inc. data for the 52 weeks ended Jan. 28.